18
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Long-Term Prognosis in Idiopathic Membranoproliferative Glomerulonephritis

Pages 265-272 | Received 26 Apr 1993, Accepted 07 Sep 1994, Published online: 15 Feb 2010

REFERENCES

  • Antoine B, Faye C. The clinical course associated with dense deposits in the basement membranes. Kidney Int 1972; 1: 420–427.
  • Belgiojoso GB, Tarantino A, Colasanti G, Bazzi C, Guerra L, Durante A. The prognostic value of some clinical and histological parameters in membranoproliferative glomerulonephritis. Nephron 1977, 19: 250–258.
  • Bennett WM, Fassett RG, Walker RG, Fairley KF, d'Apice AJF, Kincaid-Smith P. Mesangiocapillary glomerulonephritis type II (Dense-Deposit Disease): Clinical features of progressive disease. Am J Kidney Dis 1989; XIII: 469–476.
  • Blainey JD, Brewer DB, Hardwicke J. Proteinuric glomerular disease in adults: cumulative life tables over twenty years. Q J Med 1986; 59: 557–567.
  • Bohle A, Gärtner HV, Fishbach H, Bock KD, Edel HH, Frotscher U, Kluthe R, Mönninghoff W, Scheler F. The morphological and clinical features of membranoproliferative glomerulonephritis in adults. Virchows Arch (A) 1974; 363: 213–224.
  • Bohle A, Wehrmann M, Bogenschütz O, Batz C, Vogt W, Schmitt H, Müller CA, Müller GA. The Long-term prognosis of the primary glomerulonephritides. Pathol Res Pract 1992; 188: 908–924.
  • Cameron JS, Glasgow EF, Ogg CS, White RHR. Membranoproliferative glomerulonephritis and persistent hypocomplementemia. BMJ 1970; 4: 7–14.
  • Cameron JS, Ogg CS, White RHR, Glasgow EF. The clinical features and prognosis of patients with normocomplementemic mesangiocapillary glomerulonephritis. Clin Nephrol 1973; 1: 8–13.
  • Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantler C, Haycock GB, Hicks J. Idiopathic mesangiocapillary glomerulonephritis. Am J Med 1983; 74: 175–192.
  • Churg J, Sobin LH. Renal Disease. Classification and Atlas of Glomerular Disease. Igaku-Shoin, Tokyo, New York 1982.
  • Churg J, Grishman E, Goldstein MH, Yunis SL, Porush JG. Idiopathic nephrotic syndrome in adults. N Engl J Med 1965; 272: 165–174.
  • Cox DR. Regression models and lifetables (with discussion). J R Stat Soc B 1972; 34: 187–220.
  • Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chron Dis 1958; 8: 699–712.
  • Davis AE, Schneeberger EE, Grupe WE, McCluskey RT. Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children. Clin Nephrol 1978; 9: 184–193.
  • Documenta Geigy. Scientific tables. Diem K (Ed). Sixth edition. Geigy, Basle, Switzerland 1962, p. 634.
  • Donadio JV, Slack TK, Holley KE, Ilstrup DM. Idiopathic membranoproliferative (mesangiocapillary) glomerulonephritis. Mayo Clin Proc 1979; 54: 141–150.
  • Habib R, Gubler MC, Loirat C, Maiz HB, Levy M. Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney Int 1975; 7: 204–215.
  • Habib R, Kleinknecht C. The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases. In: Sommers SC, ed. Pathology Annual. New York: Appleton-Century-Crofts, 1971; 6: 417–474.
  • Habib R, Kleinknecht C, Gubler MC, Levy M. Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. Clin Nephrol 1973; 1: 194–214.
  • Herdman RC, Pickering RJ, Michael AF, Vernier RL, Fish AJ, Gewurz H, Good RA. Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis) Medicine (Baltimore) 1970; 49: 207–226.
  • Holland NH, Bennett NM. Hypocomplementemic (membranoproliferative) glomerulonephritis. Am J Dis Child 1972; 123: 439–445.
  • Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Soc C 1958; 53: 457–481.
  • Kincaid-Smith P. The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function. Med J Aust 1972; 2: 587–592.
  • Klein M, Poucell S, Arbus GS, McGraw M, Rance CP, Yoon S-J, Baumal R. Characteristics of benign subtype of dense deposit disease: comparison with the progressive form of disease. Clin Nephrol 1983; 20: 163–171.
  • Lamb V, Tisher C, McCoy RC, Robinson R. Membranoproliferative glomerulonephritis with dense intramembranous alterations. Lab Invest 1977; 36: 607–617.
  • Magil AB, Price JDE, Bower G, Range CP, Huber J, Chase WH. Membranoproliferative glomerulonephritis type 1: comparison of natural history in children and adults. Clin Nephrol 1979; 11: 239–244.
  • Mandalenakis N, Mendoza N, Pirani CL. Lobular glomerulonephritis and membranoproliferative glomerulonephritis. Medicine (Baltimore) 1971; 50: 319–355.
  • McAdams AJ, McEnery PT, West CD. Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long-term alternate prednisone therapy. J Pediatr 1975; 86: 23–31.
  • McEnery PT, McAdams PT, West CD. Membranoproliferative glomerulonephritis: improved survival with alternate day therapy. Clin Nephrol 1980; 13: 117–124.
  • McEnery PT, McAdams AJ, West CD. The effect of prednisone in a high-dose, alternateday regimen on the natural history of idiopathic membranoproliferative glomerulonephritis. Medicine (Baltimore) 1986: 64: 401–424.
  • Orlowski T, Rancewicz Z, Lao M, Juskowa J, Klepacka J, Gradowska L, Morzycka-Michalik M, Glyda J. Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis. Klin Wochenschr 1988; 66: 1019–1023.
  • Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W. Long-term Prognosis of Membranoproliferative Glomerulonephritis Type I. Nephron 1990; 55: 242–250.
  • Schwartz GJ, Haycock GB, Chir B, Spitzer A. Plasma creatinine and urea concentration in children: Normal values for age and sex. J Pediatr 1976; 88: 828–830.
  • Southwest Pediatric Nephrology Study Group. Dense deposit disease in children: prognostic value of clinical and pathologic indices. Am J Kidney Dis 1985; 6: 161–169.
  • Southwest Pediatric Nephrology Study Group. Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. Kidney Int 1985; 27: 442–449.
  • Strife CF, Jackson EC, McAdams AI. Type III membranoproliferative glomerulonephritis: long-term clinical and morphological evaluation. Clin Nephrol 1984; 21: 323–334.
  • Strife CF, McAdams AJ, West CD. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions. Clin Nephrol 1982; 18: 9–16.
  • Swainson CP, Robson JS, Thomson D, MacDonald MK. Mesangiocapillary glomerulonephritis: a long-term study of 40 cases. J Pathol 1983; 141: 449–468.
  • Vargas R, Thomson KJ, Wilson D, Cameron JS, Turner DR, Gill D, Chantler C, Ogg CS. Mesangiocapillary glomerulonephritis with dense “deposits” in the basement membranes of the kidney. Clin Nephrol 1976; 5: 73–82.
  • Warady BA, Guggenheim SJ, Sedman A, Lum GM. Prednisone therapy of membranoproliferative glomerulonephritis in children. J Pediatr 1985; 107: 702–707.
  • Watson AR, Poucell S, Thorner P, Arbus GS, Rance CP, Baumal R. Membranoproliferative glomerulonephritis type I in children: Correlation of clinical features with pathologic subtypes. Am J Kidney Dis 1984; 4: 141–146.
  • West CD. Childhood membranoproliferative glomerulonephritis: an approach to management. Kidney Int 1986; 29: 1077–1093.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.